Dai­ichi Sankyo looks to bring FLT3 drug back from the dead with late-stage win in ear­ly AML pa­tients

4 years ago
R&D

FDA au­tho­rizes mR­NA boost­ers from Pfiz­er, Mod­er­na for all adults 6 months af­ter vac­ci­na­tion

4 years ago
Coronavirus

Bench­ling adds an­oth­er megaround in­to the fold, look­ing even more uni­corn-y as a pos­si­ble IPO ap­proach­es

4 years ago
Financing

As J&J moves to split its busi­ness, ex­ecs lay out fu­ture R&D fo­cus — and tout megablock­buster po­ten­tial

4 years ago
R&D
Pharma

Safe­ty threat forces Enan­ta to scrap HBV tri­als — send­ing dis­cov­ery team back to draw­ing board

4 years ago
R&D

In­dus­try gets the edge: Medicare drug price ne­go­ti­a­tions will on­ly cost bio­phar­ma 10 drugs over the next 30 years

4 years ago
Financing
Pharma

Mer­ck hits the brakes on de­vel­op­ment pro­gram as safe­ty fears trig­ger alarm

4 years ago
R&D

Take­da on­col­o­gy vet drills down the 'ba­sic­s' at cell ther­a­py start­up; Sarep­ta pro­motes new R&D chief

4 years ago
Peer Review

Ex­clu­sive: FDA prob­ing death of Aduhelm pa­tient as Bio­gen's Alzheimer's drug con­tin­ues to stir con­tro­ver­sy

4 years ago
FDA+

Stem cell spe­cial­ist Ncar­dia bags new funds to help scale man­u­fac­tur­ing ops

4 years ago
Cell/Gene Tx
Manufacturing

Could Pitts­burgh be­come a new bio­phar­ma hub? Acad­e­mia, non­prof­it team up on $100M grant to en­tice in­dus­try

4 years ago
Manufacturing

Hov­ione plots glob­al ex­pan­sion project, look­ing to boost ca­pac­i­ty on both sides of the At­lantic

4 years ago
Manufacturing

White House preps to pump bil­lions in­to mR­NA vac­cine man­u­fac­tur­ing ca­pac­i­ty — but Mod­er­na and Pfiz­er will have to ...

4 years ago
Manufacturing

WuXi of­fi­cial­ly opens cell and gene ther­a­py site in Philly; An­oth­er mas­sive man­u­fac­tur­ing site comes to NC

4 years ago
News Briefing
Cell/Gene Tx

South Ko­re­an drug­mak­er SK looks to take over Philly CD­MO's op­er­a­tions

4 years ago
Manufacturing

Ther­mo Fish­er re­veals new home for its planned NC site with plans to up pipette man­u­fac­tur­ing

4 years ago
Manufacturing

Months af­ter mas­sive Ipsen deal, BAKX Ther­a­peu­tics nets more cash for its 'Thel­ma and Louise' ap­proach to can­cer cell ...

4 years ago
Financing

J&J un­corks long-term da­ta for Crohn's dis­ease can­di­date; Age-re­lat­ed dis­ease biotech earns Eli Lil­ly's back­ing

4 years ago
News Briefing

En­do part­ners up with US gov­ern­ment on $120M in­fu­sion in­to the na­tion­al stock­pile

4 years ago
Manufacturing

Bridge­Bio bor­rows $750M ahead of key PhI­II read­out, as it looks to wrap up buzzy 2021

4 years ago
Financing

Covid-19 roundup: Pfiz­er lands mas­sive $5B+ deal with US for po­ten­tial pill; Boost­ers for all adults are in­com­ing

4 years ago
Coronavirus

Are the stars lin­ing up for a ma­jor M&A deal at No­var­tis?

4 years ago
Bioregnum

No­vo Nordisk swal­lows Dicer­na and its RNAi pipeline in $3.3B buy­out

4 years ago
Deals

Mer­ck­'s Keytru­da scores first win in ad­ju­vant kid­ney can­cer, giv­ing it a leg up on check­point in­hibitor ri­vals

4 years ago
FDA+
First page Previous page 620621622623624625626 Next page Last page
A service from the Financial Times